These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor. Martinez AA, Espinosa BA, Adamek RN, Thomas BA, Chau J, Gonzalez E, Keppetipola N, Salzameda NT. Eur J Med Chem; 2018 Sep 05; 157():1202-1213. PubMed ID: 30193218 [Abstract] [Full Text] [Related]
5. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease. Skoreński M, Milewska A, Pyrć K, Sieńczyk M, Oleksyszyn J. J Enzyme Inhib Med Chem; 2019 Dec 05; 34(1):8-14. PubMed ID: 30362835 [Abstract] [Full Text] [Related]
6. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold. Samanta S, Lim TL, Lam Y. ChemMedChem; 2013 Jun 05; 8(6):994-1001. PubMed ID: 23619931 [Abstract] [Full Text] [Related]
7. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. Nat Struct Mol Biol; 2006 Apr 05; 13(4):372-3. PubMed ID: 16532006 [Abstract] [Full Text] [Related]
9. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease. Schöne T, Grimm LL, Sakai N, Zhang L, Hilgenfeld R, Peters T. Antiviral Res; 2017 Oct 05; 146():174-183. PubMed ID: 28927677 [Abstract] [Full Text] [Related]
10. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease. Ang MJ, Lim HA, Poulsen A, Wee JL, Ng FM, Joy J, Hill J, Chia CS. J Enzyme Inhib Med Chem; 2016 Oct 05; 31(sup2):194-200. PubMed ID: 27241372 [Abstract] [Full Text] [Related]
11. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors. Adamek RN, Maniquis RV, Khakoo S, Bridges MD, Salzameda NT. Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4848-50. PubMed ID: 23886689 [Abstract] [Full Text] [Related]
12. Potential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication. Tseng AC, Nerurkar VR, Neupane KR, Kae H, Kaufusi PH. Viruses; 2021 Jan 31; 13(2):. PubMed ID: 33572517 [Abstract] [Full Text] [Related]
15. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM. Bioorg Med Chem; 2022 Mar 01; 57():116631. PubMed ID: 35123179 [Abstract] [Full Text] [Related]
16. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase. Chernov AV, Shiryaev SA, Aleshin AE, Ratnikov BI, Smith JW, Liddington RC, Strongin AY. J Biol Chem; 2008 Jun 20; 283(25):17270-8. PubMed ID: 18442976 [Abstract] [Full Text] [Related]
17. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA. Antivir Chem Chemother; 2011 May 12; 21(5):209-17. PubMed ID: 21566267 [Abstract] [Full Text] [Related]
19. Characterization of the West Nile virus protease substrate specificity and inhibitors. Mueller NH, Yon C, Ganesh VK, Padmanabhan R. Int J Biochem Cell Biol; 2007 May 12; 39(3):606-14. PubMed ID: 17188926 [Abstract] [Full Text] [Related]